-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Deepening Cooperation and Jointly Pioneering a New Journey: L’Oréal Group Delegation Visits Keyuan Pharmaceutical for Inspection and Exchange
Publish Time:
2026-03-27
From March 26 to 27, a delegation led by ELSHEIKH Tarek, Global Director of Resource Development at global beauty giant L’Oréal Group, visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. Li Hongfu, Chairman of Keyuan Pharmaceutical, together with heads of relevant departments, extended a warm welcome. The two sides held in-depth discussions on key issues such as deepening strategic cooperation and jointly expanding into global markets, reaching multiple agreements.
From March 26 to 27, a delegation led by ELSHEIKH Tarek, Global Director of Resource Development at the global beauty giant L’Oréal Group, visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. Li Hongfu, Chairman of Keyuan Pharmaceutical, together with heads of relevant departments, extended a warm welcome. The two sides held in-depth discussions on key issues such as deepening strategic cooperation and jointly expanding into global markets, reaching multiple agreements.
Founded in 1907 and headquartered in Clichy, France, L’Oréal Group operates in 150 countries and regions worldwide. As a global leader in the beauty industry, the company leverages its strong market influence and relentless drive for innovation to set the pace for industry trends around the globe.
During the visit, the Keyuan Pharmaceutical team provided a detailed overview of the company’s post-IPO performance, its core technological strengths, and its future strategic roadmap, with particular emphasis on its competitive advantages in product R&D, quality control, and supply-chain assurance. The L’Oréal delegation expressed sincere gratitude for the longstanding close collaboration between the two companies and highly commended Keyuan Pharmaceutical’s professional excellence in product quality, supply stability, and customer service. They underscored that Keyuan Pharmaceutical, as a trusted core partner, has provided solid support for the continued expansion of L’Oréal Group’s global operations, and conveyed their strong commitment to further deepening all-round cooperation, jointly exploring additional global markets, and achieving mutually beneficial, win-win outcomes.
This visit and exchange have further strengthened the strategic partnership between the two parties, laying a solid foundation for deeper and broader collaboration in the future. Keyuan Pharmaceutical will continue to leverage its technological expertise and production capacity, uphold stringent quality standards, and deliver even higher-quality products and services to L’Oréal Group. Together, the two companies will work hand in hand to drive the high-quality development of the global beauty industry.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline